文献速递眼底病与葡萄膜炎小儿眼科与斜弱视

整合胎盘与新生儿危险因素的早产儿视网膜病变早期预测模型

Early Prediction Model for Retinopathy of Prematurity Using Placental and Neonatal Risk Factors.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2026-01-01

本研究纳入591例胎龄≤32周和/或出生体重≤1500克的早产儿,回顾性收集数据并检查胎盘组织学异常,构建PAPROP模型(含胎龄、出生体重、机械通气、产后皮质类固醇、严重组织学绒毛膜羊膜炎及远端绒毛发育不良)。该模型在生后第二周末预测ROP的判别能力为0.81(95%CI 0.76-0.86),优于仅用胎龄和出生体重的参考模型(0.78),在10%阈值下灵敏度0.97、特异度0.44,采用10%-15%临床阈值可减少25%的ROP筛查且不漏诊2期及严重ROP。

要点

  • PAPROP模型在生后第二周末即可预测ROP,判别能力0.81。
  • 10%-15%阈值下可减少25%筛查且不漏诊2期及严重ROP。
  • 模型需外部验证后方可用于高危新生儿个体化预防。

核心结论

  • PAPROP模型在生后第二周末对ROP发展具有高预测能力,临床效用潜力高且可能成本效益好。
  • 经进一步外部验证后,该模型可能有助于为高危新生儿制定个体化ROP预防治疗策略。

研究设计与样本

  • 回顾性研究纳入591例胎龄≤32周和/或出生体重≤1500克的早产儿,并检查胎盘组织学异常。

主要发现

  • PAPROP模型判别ROP存在与不存在的曲线下面积为0.81(95%CI 0.76-0.86),参考胎龄和出生体重模型为0.78。
  • 在测试集中阈值10%时,PAPROP模型灵敏度0.97、特异度0.44。
  • 采用10%至15%临床相关阈值,在生后第二周实施该模型可减少25%的ROP筛查,且不漏诊2期及严重ROP。

关键数值与推荐

  • PAPROP模型纳入变量:胎龄、出生体重、机械通气、产后皮质类固醇、严重组织学绒毛膜羊膜炎及远端绒毛发育不良。
  • 模型采用五折交叉验证进行内部验证,并与仅使用胎龄和出生体重的参考模型比较。

临床怎么用

  • 可在生后第二周应用PAPROP模型识别ROP高危新生儿,考虑在新生儿治疗中早期干预。
  • 采用10%至15%阈值可减少ROP筛查负担而不遗漏2期及严重ROP。

局限性

  • 本研究为回顾性数据收集,模型仅进行内部验证,需进一步外部验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Existing prediction models for retinopathy of prematurity (ROP) primarily focus on screening reduction which occur 5 to 7 weeks after birth. We hypothesized that high-risk neonates could be identified much earlier if placental and early postnatal risk factors are incorporated, so that this high risk can be considered during neonatal treatment well before ROP screening begins. METHODS: We included 591 neonates born ≤32 weeks of gestational age (GA) and/or birthweight (BW) ≤1500 grams. Data were retrospectively collected, and placentas were examined for histological abnormalities. The "Placenta as an Additional Predictor for ROP" (PAPROP) model included: GA, BW, mechanical ventilation, postnatal corticosteroids, severe histological chorioamnionitis, and distal villous hypoplasia. This model was internally validated with five-fold cross-validation and compared to a reference model using only GA and BW. RESULTS: The PAPROP model had a discriminatory ability between ROP presence and absence of 0.81 (95% confidence interval [CI] = 0.76-0.86) compared to 0.78 in the reference GA&BW model. This model had a sensitivity of 0.97 and specificity of 0.44 in the test set (threshold 10%). Using clinically relevant thresholds of 10% to 15%, implementing this model in the second postnatal week could lead to a 25% reduction in ROP screenings without missing stage 2 and severe ROP. CONCLUSIONS: The PAPROP model has a high ability to predict ROP development at the end of the second postnatal week, has a potential high clinical utility, and is likely cost-effective. After further external validation, it may aid in creating a personalized neonatal treatment approach for ROP prevention in high-risk neonates.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. El Emrani S, Doornkamp F, Goeman JJ, et al. Early Prediction Model for Retinopathy of Prematurity Using Placental and Neonatal Risk Factors. Invest Ophthalmol Vis Sci. 2026. PMID: 42307182. doi:10.1167/iovs.67.6.35

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。